Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Base-excision restriction enzymes: expanding the world of epigenetic immune systems. | DNA Res | 2023 | 37148195 | PubTator, text mining | PubMed |
| The genetic determinants of recurrent somatic mutations in 43,693 blood genomes. | Sci Adv | 2023 | 37126548 | PubTator, text mining | PubMed |
| In Silico Copy Number Variation (CNVs) Bioinformatics Estimation: Dream or Nightmare? | EJIFCC | 2023 | 37124656 | PubTator, text mining | PubMed |
| mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin. | Sci Rep | 2023 | 37120454 | PubTator, text mining | PubMed |
Susceptibility to Colorectal Cancer Based on HSD17B4 rs721673 and rs721675 Polymorphisms and Alcohol Intake among Taiwan Biobank Participants: A Retrospective Case Control Study Using the Nationwide Claims Data. | J Pers Med | 2023 | 37108962 | PubTator, text mining | PubMed |
| Natural Compounds Targeting the Autophagy Pathway in the Treatment of Colorectal Cancer. | Int J Mol Sci | 2023 | 37108476 | PubTator, text mining | PubMed |
| Comprehensive Genetic Analysis of Druze Provides Insights into Carrier Screening. | Genes (Basel) | 2023 | 37107695 | PubTator, text mining | PubMed |
| Young-onset colorectal cancer. | Nat Rev Dis Primers | 2023 | 37105987 | PubTator, text mining | PubMed |
| A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome. | J Transl Med | 2023 | 37101184 | PubTator, text mining | PubMed |
| What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database. | Cancer Med | 2023 | 37096751 | PubTator, text mining | PubMed |
| The Unique Spectrum of MUTYH Germline Mutations in Colombian Patients with Extracolonic Carcinomas. | Appl Clin Genet | 2023 | 37096204 | PubTator, text mining | PubMed |
| Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing. | BMC Genomics | 2023 | 37095444 | PubTator, text mining | PubMed |
| Genomic profiling of idiopathic peri-hilar cholangiocarcinoma reveals new targets and mutational pathways. | Sci Rep | 2023 | 37095160 | PubTator, text mining | PubMed |
| Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature. | Thorac Cancer | 2023 | 37095004 | PubTator, text mining | PubMed |
| 8-Oxo-2'-deoxyguanosine Replication in Mutational Hot Spot Sequences of the p53 Gene in Human Cells Is Less Mutagenic than That of the Corresponding Formamidopyrimidine. | Chem Res Toxicol | 2023 | 37093780 | PubTator, text mining | PubMed |
| Multi-omics analysis of the Indian ovarian cancer cohort revealed histotype-specific mutation and gene expression patterns. | Front Genet | 2023 | 37091785 | PubTator, text mining | PubMed |
| Roles of DNA damage in renal tubular epithelial cells injury. | Front Physiol | 2023 | 37089416 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts Are Key Determinants of Cancer Cell Invasion in the Earliest Stage of Colorectal Cancer. | Cell Mol Gastroenterol Hepatol | 2023 | 37085135 | PubTator, text mining | PubMed |
| The association between age at breast cancer diagnosis and prevalence of pathogenic variants. | Breast Cancer Res Treat | 2023 | 37084156 | PubTator, text mining | PubMed |
| Diagnostic yield of genetic screening in a diverse, community-ascertained cohort. | Genome Med | 2023 | 37069702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=25